HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yoshimitsu Yamasaki Selected Research

Lipids

1/2013Improved lipid profiles are associated with reduced incidence of coronary vascular events in asymptomatic patients with type 2 diabetes and impaired myocardial perfusion.
2/2011Usefulness of lipoprotein ratios in assessing carotid atherosclerosis in Japanese type 2 diabetic patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yoshimitsu Yamasaki Research Topics

Disease

32Type 2 Diabetes Mellitus (MODY)
04/2017 - 07/2002
24Insulin Resistance
01/2009 - 01/2002
10Atherosclerosis
02/2011 - 02/2003
9Carotid Artery Diseases
01/2014 - 08/2002
6Hypertension (High Blood Pressure)
01/2014 - 01/2004
5Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 09/2006
5Type 1 Diabetes Mellitus (Autoimmune Diabetes)
05/2009 - 08/2002
5Hyperglycemia
07/2007 - 02/2003
4Abdominal Obesity
01/2013 - 03/2009
3Diabetic Retinopathy (Retinopathy, Diabetic)
06/2015 - 07/2008
3Diabetes Complications
11/2011 - 09/2008
3Glucose Intolerance
01/2009 - 01/2002
3Diabetic Angiopathies (Diabetic Angiopathy)
07/2008 - 10/2005
2Hyperkalemia
02/2021 - 04/2017
2Diabetic Nephropathies (Diabetic Nephropathy)
04/2017 - 01/2013
2Albuminuria
04/2017 - 02/2011
2Stroke (Strokes)
02/2014 - 01/2014
2Hyperlipidemias (Hyperlipidemia)
02/2014 - 01/2004
2Dyslipidemias (Dyslipidemia)
01/2014 - 08/2009
2Cerebral Infarction
01/2014 - 01/2004
2Edema (Dropsy)
12/2009 - 08/2008
2Obesity
07/2007 - 11/2004
1Chronic Disease (Chronic Diseases)
02/2021
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2013
1IGA Glomerulonephritis (IGA Nephropathy)
03/2012
1Coronary Disease (Coronary Heart Disease)
11/2011
1Peripheral Arterial Disease
06/2010
1Myocardial Infarction
05/2010
1Isolated Systolic Hypertension
08/2009
1Infections
08/2008
1Pleural Effusion (Pleural Effusions)
08/2008
1Cerebrovascular Disorders (Cerebrovascular Occlusion)
01/2008
1Chronic Obstructive Pulmonary Disease (COPD)
01/2008
1Body Weight (Weight, Body)
11/2007

Drug/Important Bio-Agent (IBA)

21Glucose (Dextrose)FDA LinkGeneric
08/2008 - 01/2002
16Insulin (Novolin)FDA Link
12/2009 - 01/2002
6Biomarkers (Surrogate Marker)IBA
02/2011 - 01/2004
5Pioglitazone (Actos)FDA Link
01/2014 - 04/2007
5Triglycerides (Triacylglycerol)IBA
01/2013 - 08/2009
5HDL CholesterolIBA
01/2013 - 08/2009
4AlbuminsIBA
01/2013 - 07/2008
3CreatinineIBA
01/2013 - 12/2009
3Oxygen (Dioxygen)IBA
05/2010 - 01/2005
3Advanced Glycation End ProductsIBA
05/2009 - 11/2005
3human esRAGE proteinIBA
05/2009 - 11/2005
3Indicators and Reagents (Reagents)IBA
03/2009 - 02/2008
3Proteins (Proteins, Gene)FDA Link
07/2007 - 01/2005
3JNK Mitogen-Activated Protein KinasesIBA
01/2006 - 10/2004
3AntioxidantsIBA
11/2005 - 07/2002
2Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
06/2015 - 07/2010
2CopperIBA
01/2013 - 01/2009
2LipidsIBA
01/2013 - 02/2011
2Reactive Oxygen Species (Oxygen Radicals)IBA
01/2013 - 01/2009
2AdiponectinIBA
02/2012 - 07/2007
2oxidized low density lipoproteinIBA
02/2011 - 01/2002
2Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
06/2010 - 08/2006
2Cilostazol (Pletal)FDA LinkGeneric
06/2010 - 08/2006
21,2- diarachidonoyl- glycero- 3- phosphocholineIBA
06/2010 - 08/2006
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2010 - 08/2006
2Pharmaceutical PreparationsIBA
08/2009 - 01/2004
2Sucrose (Saccharose)IBA
01/2009 - 02/2008
2Blood Glucose (Blood Sugar)IBA
07/2008 - 10/2004
2Probucol (Lorelco)FDA Link
11/2005 - 07/2002
2Molecular Chaperones (Chaperone, Molecular)IBA
03/2005 - 01/2005
24- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA
02/2003 - 01/2002
2NADPH Oxidases (NAD(P)H oxidase)IBA
02/2003 - 01/2002
1sodium zirconium cyclosilicateIBA
02/2021
1CationsIBA
02/2021
1PotassiumIBA
04/2017
1finerenoneIBA
04/2017
1Pravastatin (Pravachol)FDA LinkGeneric
02/2014
1CholesterolIBA
02/2014
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
02/2014
1Peroxidase (Myeloperoxidase)IBA
01/2013
15-Methyltetrahydrofolate-Homocysteine S-Methyltransferase (Methyltetrahydrofolate Homocysteine Methyltransferase)IBA
03/2012
1LDL CholesterolIBA
11/2011
1Glyburide (Glibenclamide)FDA LinkGeneric
04/2011
1glimepiride (Amarel)FDA LinkGeneric
04/2011
1Lipoproteins (Lipoprotein)IBA
02/2011
1Monocyte Chemoattractant ProteinsIBA
07/2010
1Phosphodiesterase InhibitorsIBA
06/2010
1Antihypertensive Agents (Antihypertensives)IBA
08/2009
1Chelating AgentsIBA
01/2009
1tetrathiomolybdate (ammonium tetrathiomolybdate)IBA
01/2009
1Glycated ProteinsIBA
07/2008
1Glycated Hemoglobin (Glycosylated Hemoglobin)IBA
07/2008
1pigment epithelium-derived factorIBA
07/2008
1Ointments (Pastes)IBA
03/2008
1nafamostatIBA
03/2008
1Green Fluorescent ProteinsIBA
02/2008
1Keratins (Keratin)IBA
11/2007
1AmylasesFDA Link
11/2007
1Glucagon (Glukagon)FDA Link
11/2007
1N 30IBA
07/2007

Therapy/Procedure

8Therapeutics
02/2021 - 06/2005
3Glycemic Control
01/2013 - 07/2008
2Secondary Prevention
01/2022 - 02/2014
1Transplantation
08/2008
1Kidney Transplantation
08/2008
1Light Coagulation
01/2008